Seven new blood clot cases after vaccine
There have been seven new blood clot cases following the AstraZeneca vaccine, the Therapeutic Goods Administration has revealed.
The new cases of thrombosis with thrombocytopenia syndrome (TTS) were revealed in the TGA's COVID-19 vaccine weekly safety report on Thursday.
Three cases were confirmed as TTS, while four were deemed probable.
The three confirmed cases included a 75-year-old man from Victoria, a 75-year-old man from Western Australia and a 59-year-old Queensland man who was diagnosed in Victoria.
"Of these, only the Victorian man remains in hospital, but is responding to treatment and is in a stable condition," a TGA statement read.
"The other two patients are not currently in hospital and are thought to be well.
"Four other newly reported cases are considered to be probable TTS. This includes three men from Victoria aged 65, 70 and 81 years, and a 70-year-old man from NSW."
All but one of the newly reported cases was vaccinated after the April 8 recommendation by ATAGI that Comirnaty was preferred over the AstraZeneca vaccine in adults aged under 50 years.
The developments take the total Australian reports of cases assessed as TTS following the AstraZeneca vaccine to 18.
About 1.8 million doses of the AstraZeneca vaccine have been administered so far.
More to come
Originally published as Seven new blood clot cases after vaccine